Rankings
▼
Calendar
CAI (Caris Life Sciences, Inc.) Stock Financials & Earnings | Market Cap Arena
CAI
Caris Life Sciences, Inc.
Mkt Cap
$5B
Healthcare
·
Biotechnology
·
🇺🇸 United States
·
NASDAQ
Revenue (TTM)
$812M
Net Income (TTM)
-$538M
EPS (TTM)
-$1.91
Free Cash Flow (TTM)
$33M
Gross Margin
66.4%
Op. Margin
5.6%
Net Margin
-66.2%
FCF Margin
4.0%
P/S Ratio (TTM)
6.5x
P/E Ratio (TTM)
—
YoY Rev Growth
+121.1%
Employees
—
Earnings Reports
▶
Q4 2025
NEW
Browse All Reports
Quarterly
FY
Revenue & Profitability
Revenue
Gross Profit
Operating Income
Quarter
Revenue
Gross Profit
Op. Income
Q2 20
$76M
$47M
$33M
Q3 20
$79M
$49M
$36M
Q4 20
$64M
$41M
$36M
Q1 21
$81M
$39M
$49M
Q2 21
$86M
$43M
$51M
Q3 21
$101M
$54M
$66M
Q1 24
$81M
$26M
-$92M
Q2 24
$100M
$38M
$67M
Q1 25
$121M
$57M
-$58M
Q2 25
$181M
$114M
$18M
Q3 25
$217M
$148M
$33M
Q4 25
$293M
$221M
$52M
marketcaparena.com
Valuation
P/S Ratio
P/E Ratio
Quarter
P/S
P/E
Q2 20
13.7x
4638.7x
Q3 20
14.8x
249.2x
Q4 20
16.4x
191.7x
Q1 21
17.7x
82.0x
Q2 21
17.2x
51.4x
Q3 21
16.0x
38.2x
Q1 24
15.3x
384.9x
Q2 24
14.5x
—
Q1 25
13.2x
—
Q2 25
11.0x
—
Q3 25
8.6x
—
Q4 25
6.5x
—
marketcaparena.com
Operating Cash Flow
Operating Cash Flow
Free Cash Flow
Quarter
Operating CF
Free CF
Q2 20
$66M
$60M
Q3 20
$73M
$56M
Q4 20
$79M
-$91M
Q1 21
$76M
-$96M
Q2 21
$86M
-$19M
Q3 21
$98M
-$448M
Q1 24
-$74M
-$76M
Q2 24
-$63M
-$66M
Q1 25
-$31M
-$34M
Q2 25
$7M
$6M
Q3 25
$62M
$55M
Q4 25
$13M
$6M
marketcaparena.com
Capital Expenditures
CapEx
Quarter
CapEx
Q2 20
$5M
Q3 20
$16M
Q4 20
$170M
Q1 21
$172M
Q2 21
$105M
Q3 21
$545M
Q1 24
$2M
Q2 24
$3M
Q1 25
$3M
Q2 25
$1M
Q3 25
$7M
Q4 25
$8M
marketcaparena.com
OpEx vs Revenue Growth (YoY)
Revenue Growth
OpEx Growth
Quarter
Revenue Growth
OpEx Growth
Q2 20
-28.3%
-40.0%
Q3 20
-26.5%
-40.5%
Q4 20
-35.8%
-60.8%
Q1 21
-23.1%
-55.2%
Q2 21
+13.2%
-18.4%
Q3 21
+27.5%
-21.0%
Q1 24
+25.4%
+511.9%
Q2 24
+23.8%
+3.1%
Q1 25
+41.1%
+413.2%
Q2 25
+79.9%
+375.2%
Q3 25
+168.8%
+6.5%
Q4 25
+192.7%
+627.8%
marketcaparena.com
Stock-Based Compensation
SBC ($)
% of Revenue
Quarter
SBC ($)
% of Revenue
Q2 20
-$73K
-0.1%
Q3 20
$615K
0.8%
Q4 20
$359K
0.6%
Q1 21
$540K
0.7%
Q2 21
$593K
0.7%
Q3 21
$566K
0.6%
Q1 24
$4M
5.5%
Q2 24
$4M
4.5%
Q1 25
$15M
12.1%
Q2 25
$28M
15.6%
Q3 25
$14M
6.3%
Q4 25
$28M
9.6%
marketcaparena.com
OpEx Breakdown
R&D
G&A
S&M
Quarter
R&D
G&A
S&M
Q2 20
—
$7M
$6M
Q3 20
—
$6M
$7M
Q4 20
—
$6M
—
Q1 21
—
$8M
—
Q2 21
—
$10M
—
Q3 21
—
$12M
—
Q1 24
$34M
$45M
$38M
Q2 24
$25M
$41M
$39M
Q1 25
$23M
$53M
$39M
Q2 25
$25M
$64M
$42M
Q3 25
$22M
$52M
$41M
Q4 25
$34M
$55M
$45M
marketcaparena.com
Revenue by Geography
Non-US
United States
Quarter
Non-US
United States
Q2 25
$3M
$178M
Q3 25
$3M
$214M
marketcaparena.com
War Chest
Cash & Equivalents
Short-Term Investments
Quarter
Cash
Short-term Investments
Total
Q4 19
$46M
$0
$46M
Q1 20
$109M
$0
$109M
Q2 20
$48M
$0
$48M
Q3 20
$42M
$75M
$118M
Q4 20
$54M
$79M
$133M
Q1 21
$48M
$0
$48M
Q2 21
$39M
$0
$39M
Q3 21
$47M
$0
$47M
Q1 25
$31M
$2M
$33M
Q2 25
$719M
$2M
$721M
Q3 25
$753M
$2M
$755M
Q4 25
$798M
$2M
$800M
marketcaparena.com
Shares Outstanding
Shares Outstanding
Quarter
Shares (Diluted)
QoQ Change
Q2 20
18M
+1.0%
Q3 20
18M
+0.6%
Q4 20
18M
+1.4%
Q1 21
18M
-2.4%
Q2 21
17M
-0.2%
Q3 21
18M
+0.3%
Q1 24
255M
+1353.4%
Q2 24
255M
+0.0%
Q1 25
255M
+0.0%
Q2 25
276M
+8.3%
Q3 25
297M
+7.7%
Q4 25
1.67B
+462.6%
marketcaparena.com